Patient-partnered research yields invaluable insight on rare cancer

Through a unique collaboration with affected patients, researchers have conducted the largest angiosarcoma study and uncovered clues to previously unknown causes and potential therapeutic strategies for this rare cancer, which often confers poor prognosis. As a result of the Angiosarcoma Project — a unique collaboration between affected patients and researchers — investigators from the Broad Institute of the Massachusetts Institute of Technology and Harvard, Dana-Farber Cancer Institute (both MA, USA) and Count Me In have uncovered potential new causes of angiosarcoma and possible therapeutic strategies for this rare cancer, which often confers poor prognosis. Launched in 2017, the Angiosarcoma Project...